Babkov, D.; Eliseeva, N.; Adzhienko, K.; Bagmetova, V.; Danilov, D.; McReynolds, C.B.; Morisseau, C.; Hammock, B.D.; Burmistrov, V.
Preclinical Evaluation of Soluble Epoxide Hydrolase Inhibitor AMHDU against Neuropathic Pain. Int. J. Mol. Sci. 2024, 25, 8841.
https://doi.org/10.3390/ijms25168841
AMA Style
Babkov D, Eliseeva N, Adzhienko K, Bagmetova V, Danilov D, McReynolds CB, Morisseau C, Hammock BD, Burmistrov V.
Preclinical Evaluation of Soluble Epoxide Hydrolase Inhibitor AMHDU against Neuropathic Pain. International Journal of Molecular Sciences. 2024; 25(16):8841.
https://doi.org/10.3390/ijms25168841
Chicago/Turabian Style
Babkov, Denis, Natalya Eliseeva, Kristina Adzhienko, Viktoria Bagmetova, Dmitry Danilov, Cynthia B. McReynolds, Christophe Morisseau, Bruce D. Hammock, and Vladimir Burmistrov.
2024. "Preclinical Evaluation of Soluble Epoxide Hydrolase Inhibitor AMHDU against Neuropathic Pain" International Journal of Molecular Sciences 25, no. 16: 8841.
https://doi.org/10.3390/ijms25168841
APA Style
Babkov, D., Eliseeva, N., Adzhienko, K., Bagmetova, V., Danilov, D., McReynolds, C. B., Morisseau, C., Hammock, B. D., & Burmistrov, V.
(2024). Preclinical Evaluation of Soluble Epoxide Hydrolase Inhibitor AMHDU against Neuropathic Pain. International Journal of Molecular Sciences, 25(16), 8841.
https://doi.org/10.3390/ijms25168841
